Fingerprint
Dive into the research topics of 'Exposure–response of veliparib to inform phase II trial design in refractory or relapsed patients with hematological malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Exposure–response of veliparib to inform phase II trial design in refractory or relapsed patients with hematological malignancies
Shailly Mehrotra, Mathangi Gopalakrishnan, Jogarao Gobburu, Jiuping Ji, Jacqueline M. Greer, Richard Piekarz, Judith E. Karp, Keith W. Pratz, Michelle A. Rudek
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations